Brian Cheng
Stock Analyst at J.P. Morgan
(4.59)
# 989
Out of 4,696 analysts
275
Total ratings
55%
Success rate
14.1%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintained: Buy | $246 | $209.87 | +17.22% | 18 | Sep 2, 2026 | |
| ROIV Roivant Sciences | Maintained: Buy | $40 → $41 | $34.52 | +18.77% | 26 | Sep 2, 2026 | |
| BLSM BlossomHill Therapeutics | Initiated Coverage: Buy | $28 | $18.99 | +47.45% | 1 | Sep 1, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | n/a | $82.74 | - | 5 | Aug 31, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $149 | $146.49 | +1.71% | 24 | Aug 31, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Hold | n/a | $1.99 | - | 9 | Aug 17, 2026 | |
| PLRX Pliant Therapeutics | Maintained: Sell | n/a | $1.11 | - | 3 | Aug 17, 2026 | |
| EIKN Eikon Therapeutics | Maintained: Buy | $29 | $10.88 | +166.54% | 5 | Aug 17, 2026 | |
| STTK Shattuck Labs | Maintained: Buy | $10 → $13 | $6.87 | +89.23% | 2 | Aug 12, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $65 → $72 | $56.09 | +28.37% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $39.90 | +25.31% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $27 | $14.31 | +88.68% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $29 | $24.50 | +18.37% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $29.02 | +51.62% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $119.05 | +1.64% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $22.35 | +105.82% | 1 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 → $91 | $70.56 | +28.97% | 10 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.90 | - | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.07 | - | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $12.69 | -36.93% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $8.35 | +247.31% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 → $14 | $27.91 | -49.84% | 15 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $75.86 | +26.55% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $46 | $16.23 | +183.43% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $3.07 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.67 | - | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $67 | $56.82 | +17.92% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.52 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.84 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $6.86 | n/a | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.24 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.37 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.17 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $9.26 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.34 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.1674 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $3.5 | $2.12 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $9.92 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.9741 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $86 | $16.23 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.21 | n/a | 2 | Nov 2, 2021 |
Revolution Medicines
Sep 2, 2026
Maintained: Buy
Price Target: $246
Current: $209.87
Upside: +17.22%
Roivant Sciences
Sep 2, 2026
Maintained: Buy
Price Target: $40 → $41
Current: $34.52
Upside: +18.77%
BlossomHill Therapeutics
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $18.99
Upside: +47.45%
Arrowhead Pharmaceuticals
Aug 31, 2026
Maintained: Buy
Price Target: n/a
Current: $82.74
Upside: -
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $149
Current: $146.49
Upside: +1.71%
Allogene Therapeutics
Aug 17, 2026
Maintained: Hold
Price Target: n/a
Current: $1.99
Upside: -
Pliant Therapeutics
Aug 17, 2026
Maintained: Sell
Price Target: n/a
Current: $1.11
Upside: -
Eikon Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $29
Current: $10.88
Upside: +166.54%
Shattuck Labs
Aug 12, 2026
Maintained: Buy
Price Target: $10 → $13
Current: $6.87
Upside: +89.23%
TG Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $65 → $72
Current: $56.09
Upside: +28.37%
Aug 10, 2026
Maintained: Buy
Price Target: $50
Current: $39.90
Upside: +25.31%
Aug 10, 2026
Maintained: Buy
Price Target: $31 → $27
Current: $14.31
Upside: +88.68%
Aug 10, 2026
Maintained: Buy
Price Target: $26 → $29
Current: $24.50
Upside: +18.37%
Aug 6, 2026
Maintained: Buy
Price Target: $44
Current: $29.02
Upside: +51.62%
Aug 6, 2026
Maintained: Buy
Price Target: $121
Current: $119.05
Upside: +1.64%
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $22.35
Upside: +105.82%
Jul 13, 2026
Maintained: Buy
Price Target: $89 → $91
Current: $70.56
Upside: +28.97%
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $3.90
Upside: -
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $27.07
Upside: -
May 13, 2026
Maintained: Sell
Price Target: $8
Current: $12.69
Upside: -36.93%
May 13, 2026
Rated: Buy
Price Target: $29
Current: $8.35
Upside: +247.31%
May 11, 2026
Rated: Hold
Price Target: $13 → $14
Current: $27.91
Upside: -49.84%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $75.86
Upside: +26.55%
Apr 15, 2026
Maintained: Buy
Price Target: $47 → $46
Current: $16.23
Upside: +183.43%
Mar 13, 2026
Maintained: Sell
Price Target: n/a
Current: $3.07
Upside: -
Mar 3, 2026
Maintained: Buy
Price Target: n/a
Current: $29.67
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $69 → $67
Current: $56.82
Upside: +17.92%
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.52
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $8.84
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $6.86
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.24
Upside: n/a
Jul 15, 2024
Maintained: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.17
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $9.26
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.34
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.1674
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: $33 → $3.5
Current: $2.12
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $9.92
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.9741
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $93 → $86
Current: $16.23
Upside: n/a
Nov 2, 2021
Maintained: Buy
Price Target: $14
Current: $2.21
Upside: n/a